The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immune Globulins Market Research Report 2025

Global Immune Globulins Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1794536

No of Pages : 95

Ask Your Query

Synopsis

Immune globulin (Ig) short-term protection against hepatitis A and measles

The global Immune Globulins market was valued at US$ 15220 million in 2023 and is anticipated to reach US$ 25330 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.

The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.

This report aims to provide a comprehensive presentation of the global market for Immune Globulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulins.

Report Scope

The Immune Globulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Globulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immune Globulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Takeda
  • Grifols
  • CSL
  • Octapharma
  • Biotest
  • Kedrion
  • Hualan Bio
  • CNBG
  • Shanghai RAAS
  • CBPO
  • LFB Group
  • BPL
  • Sichuan Yuanda Shuyang

Segment by Type

  • IVIg Liquid
  • IVIg Powder

Segment by Application

  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Globulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Globulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Immune Globulins Market Overview
1.1 Product Overview and Scope of Immune Globulins
1.2 Immune Globulins Segment by Type
1.2.1 Global Immune Globulins Market Value Comparison by Type (2024-2030)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Immune Globulins Segment by Application
1.3.1 Global Immune Globulins Market Value by Application: (2024-2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulins Market Size Estimates and Forecasts
1.4.1 Global Immune Globulins Revenue 2019-2030
1.4.2 Global Immune Globulins Sales 2019-2030
1.4.3 Global Immune Globulins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immune Globulins Market Competition by Manufacturers
2.1 Global Immune Globulins Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immune Globulins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immune Globulins Average Price by Manufacturers (2019-2024)
2.4 Global Immune Globulins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Globulins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Globulins, Product Type & Application
2.7 Immune Globulins Market Competitive Situation and Trends
2.7.1 Immune Globulins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immune Globulins Players Market Share by Revenue
2.7.3 Global Immune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immune Globulins Retrospective Market Scenario by Region
3.1 Global Immune Globulins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immune Globulins Global Immune Globulins Sales by Region: 2019-2030
3.2.1 Global Immune Globulins Sales by Region: 2019-2024
3.2.2 Global Immune Globulins Sales by Region: 2025-2030
3.3 Global Immune Globulins Global Immune Globulins Revenue by Region: 2019-2030
3.3.1 Global Immune Globulins Revenue by Region: 2019-2024
3.3.2 Global Immune Globulins Revenue by Region: 2025-2030
3.4 North America Immune Globulins Market Facts & Figures by Country
3.4.1 North America Immune Globulins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immune Globulins Sales by Country (2019-2030)
3.4.3 North America Immune Globulins Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Immune Globulins Market Facts & Figures by Country
3.5.1 Europe Immune Globulins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immune Globulins Sales by Country (2019-2030)
3.5.3 Europe Immune Globulins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Globulins Market Facts & Figures by Country
3.6.1 Asia Pacific Immune Globulins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immune Globulins Sales by Country (2019-2030)
3.6.3 Asia Pacific Immune Globulins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immune Globulins Market Facts & Figures by Country
3.7.1 Latin America Immune Globulins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immune Globulins Sales by Country (2019-2030)
3.7.3 Latin America Immune Globulins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Globulins Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Globulins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immune Globulins Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immune Globulins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Globulins Sales by Type (2019-2030)
4.1.1 Global Immune Globulins Sales by Type (2019-2024)
4.1.2 Global Immune Globulins Sales by Type (2025-2030)
4.1.3 Global Immune Globulins Sales Market Share by Type (2019-2030)
4.2 Global Immune Globulins Revenue by Type (2019-2030)
4.2.1 Global Immune Globulins Revenue by Type (2019-2024)
4.2.2 Global Immune Globulins Revenue by Type (2025-2030)
4.2.3 Global Immune Globulins Revenue Market Share by Type (2019-2030)
4.3 Global Immune Globulins Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immune Globulins Sales by Application (2019-2030)
5.1.1 Global Immune Globulins Sales by Application (2019-2024)
5.1.2 Global Immune Globulins Sales by Application (2025-2030)
5.1.3 Global Immune Globulins Sales Market Share by Application (2019-2030)
5.2 Global Immune Globulins Revenue by Application (2019-2030)
5.2.1 Global Immune Globulins Revenue by Application (2019-2024)
5.2.2 Global Immune Globulins Revenue by Application (2025-2030)
5.2.3 Global Immune Globulins Revenue Market Share by Application (2019-2030)
5.3 Global Immune Globulins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Immune Globulins Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Immune Globulins Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Immune Globulins Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Immune Globulins Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest Immune Globulins Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kedrion Immune Globulins Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Bio Immune Globulins Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG Immune Globulins Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS Immune Globulins Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Immune Globulins Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Immune Globulins Description and Business Overview
6.11.3 LFB Group Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LFB Group Immune Globulins Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Immune Globulins Description and Business Overview
6.12.3 BPL Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BPL Immune Globulins Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Immune Globulins Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Immune Globulins Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Yuanda Shuyang Immune Globulins Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Globulins Industry Chain Analysis
7.2 Immune Globulins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Globulins Production Mode & Process
7.4 Immune Globulins Sales and Marketing
7.4.1 Immune Globulins Sales Channels
7.4.2 Immune Globulins Distributors
7.5 Immune Globulins Customers
8 Immune Globulins Market Dynamics
8.1 Immune Globulins Industry Trends
8.2 Immune Globulins Market Drivers
8.3 Immune Globulins Market Challenges
8.4 Immune Globulins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock